Last kr88.80 SEK
Change Today -0.10 / -0.11%
Volume 1.3M
EKTAB On Other Exchanges
Symbol
Exchange
OTC US
Stockholm
OTC US
Frankfurt
As of 11:29 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

elekta ab-b shs (EKTAB) Snapshot

Open
kr89.30
Previous Close
kr88.90
Day High
kr89.95
Day Low
kr88.50
52 Week High
02/20/14 - kr99.88
52 Week Low
10/16/14 - kr63.95
Market Cap
34.0B
Average Volume 10 Days
2.1M
EPS TTM
kr2.69
Shares Outstanding
368.6M
EX-Date
08/29/14
P/E TM
33.0x
Dividend
kr1.50
Dividend Yield
2.25%
Current Stock Chart for ELEKTA AB-B SHS (EKTAB)

Related News

No related news articles were found.

elekta ab-b shs (EKTAB) Related Businessweek News

No Related Businessweek News Found

elekta ab-b shs (EKTAB) Details

Elekta AB (publ), develops and sells clinical solutions for the treatment of cancer and brain disorders worldwide. The company offers Leksell Gamma Knife, a system for cranial stereotactic radiosurgery; the Extend sytem for utilization of Leksell Gamma Knife Perfexion; and Leksell Stereotactic System for neurosurgery and biopsies. Its neuroscience solutions comprise Gamma Knife radiosurgery for the treatment of brain disorders; stereotactic neurosurgery; and surgical navigation accessories, as well as Elekta Neuromag TRIUX, a magnetoencephalography platform. The company also provides oncology treatment solutions, such as Precise Treatment System, a digital treatment system; Elekta Axesse, a stereotactic radiation therapy system; Elekta Compact, a gateway to RT for oncology centers; Elekta Synergy system that visualize tumor targets and normal tissue, and their movement between and during fractions; treatment planning systems; oncology information systems solutions; Versa HD, a linear accelerator; and Elekta Infinity system for volumetric arc modulated therapy, as well as various treatment techniques. In addition, it offers brachytherapy solutions that include afterloading platforms; real-time prostate solutions; Oncentra Brachy, a radiotherapy treatment planning system; Esteya for treating skin cancer; and applicators. Further, the company provides software products, including MOSAIQ oncology information system; Oncology Informatics/Data Alliances that streamlines the flow of information in the cancer care team; medical oncology software; Clarity Soft Tissue Visualization, a software for radiation therapy; and METRIQ, a cancer registry data solution. It also offers installation and implementation, service and support, remote, upgrades and accessories, and financial solutions, as well as training, education, and consultative services. It primarily serves hospitals and academic institutions. The company was founded in 1972 and is headquartered in Stockholm, Sweden.

3,764 Employees
Last Reported Date: 11/27/14
Founded in 1972

elekta ab-b shs (EKTAB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

elekta ab-b shs (EKTAB) Key Developments

Elekta Plans to Introduce MRI-Guided Radiation Therapy System in 2017

Elekta announced its latest research and development initiatives, with special focus on Atlantic, the first generation high field MRI-guided radiation therapy system. The company unveiled plans to introduce this game-changing technology in 2017 and deliver the first systems in 2018.

Queen Elizabeth II Medical Centre Selects MOSAIQ Oncology Information System of Elekta

As part of consolidating the cancer care of four Western Australian public services into a single, multi-disciplinary facility, the clinics will transition from their existing oncology information systems (OIS) to Elekta's MOSAIQ OIS. The conversion to MOSAIQ for radiation oncology, hematology/medical oncology and pediatric oncology at the Queen Elizabeth II Medical Centre (QEIIMC), Perth, WA, will occur in stages from mid-2015 to 2016. The consolidation comprises the Sir Charles Gairdner Hospital, Princess Margaret Hospital and the new Children's Hospital. The QEIIMC is the large medical center in the southern hemisphere and globally recognized for its health care, research and education.

Elekta Receives an Order from the Republic of Turkey's Ministry of Health for Nine Elekta Synergy Linear Accelerators

Elekta has received an order from the Republic of Turkey's Ministry of Health for nine Elekta Synergy linear accelerators, all including Agility multileaf collimators for high-resolution beam shaping, as well as Monaco 5.0 treatment planning system and MOSAIQ oncology information system.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EKTAB:SS kr88.80 SEK -0.10

EKTAB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Accuray Inc $7.37 USD -0.02
American Shared Hospital Services $2.49 USD 0.00
Eckert-Ziegler Bebig €1.39 EUR +0.037
MRI Interventions Inc $0.75 USD -0.018
RaySearch Laboratories AB kr53.75 SEK +0.25
View Industry Companies
 

Industry Analysis

EKTAB

Industry Average

Valuation EKTAB Industry Range
Price/Earnings 30.2x
Price/Sales 2.8x
Price/Book 5.2x
Price/Cash Flow 28.5x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELEKTA AB-B SHS, please visit www.elekta.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.